$AGN can't acquire $RVNC, IMO. They're not going 2shelve Botox, while shelving RT-002 would be rejected by antitrust regulators. https://t.co/9Gaz8gV0iw
$RVNC could be acquired by almost any phrma/biotech(except $AGN) w interest in neuro &/or aesthetic med.I.e. long list of potential suitors. https://t.co/0qgX7LbNca
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.